Estradiol Patch
Product Images NDC 0378-4622

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Estradiol (NDC 0378-4622). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Export 00

Illustration depicting the proper placement of the Estradiol transdermal patch on the lower abdomen on both the left and right sides, demonstrating correct application areas for the patch.*

FDA Label Image

Export 01

Instructional illustration showing the application of an Estradiol transdermal patch on the lower abdomen. Figure E depicts placement slightly above the hip on the side, while Figure F shows placement on the front lower abdomen area. The images demonstrate proper patch positioning on the skin.*

FDA Label Image

Export 02

An instructional illustration showing two hands peeling apart a backing from a transdermal patch, demonstrating how to open and prepare the patch for application.*

FDA Label Image

Export 03

An instructional illustration showing hands peeling back the covering of an Estradiol transdermal patch packet. The packet is labeled with 'Estradiol' and doses including .025 mg/d, .0375 mg/d, .05 mg/d, .075 mg/d, and .1 mg/d. The label also indicates the product is from Mylan Pharmaceuticals Inc.*

FDA Label Image

Export 04

An instructional illustration showing a hand using a pen or marker to write on the printed application schedule inside an Estradiol transdermal patch box. The illustration highlights the importance of tracking the weekly application days of the patch and includes usage instructions printed on the box flap.*

FDA Label Image

Export 05

Illustration showing the packaging contents of Estradiol transdermal patches by Mylan Pharmaceuticals Inc. It includes a carton labeled with Estradiol 0.05 mg/day (twice-weekly), a calendar-type holder for patches, a pouch containing an individual patch, and prescribing information and patient information leaflet.*

FDA Label Image

Export 06

A line chart illustrating the percentage change from baseline over a 104-week treatment duration for different dosages of Estradiol transdermal patches and placebo. The x-axis represents treatment duration in weeks (26, 52, 78, 104), and the y-axis shows percent change from baseline. Lines represent doses of 0.1 mg/day, 0.05 mg/day, 0.0375 mg/day, 0.025 mg/day, and placebo, with statistical significance markers comparing groups.*

FDA Label Image

Export 07

A line graph showing the percentage change from baseline over treatment duration (weeks 26, 52, 78, and 104) for Estradiol transdermal patches at doses 0.025 mg/day, 0.0375 mg/day, 0.05 mg/day, 0.1 mg/day, and placebo. Each dose is represented with distinct line styles and markers.*

FDA Label Image

Export 08

Bar chart showing mean reductions from baseline over 12 weeks comparing Vivelle 0.0375 mg/day and placebo. The chart indicates larger mean reductions with Vivelle at weeks 4, 8, and 12, each with standard deviations and sample sizes. Statistically significant differences are noted between Vivelle and placebo at all time points.*

FDA Label Image

Export 09

A line graph showing serum concentration (pg/mL) over time (days) for estradiol transdermal patches at three different daily doses: 0.1 mg, 0.05 mg, and 0.025 mg. The graph depicts concentration levels rising sharply at day 0, peaking, and then gradually declining by day 5 for each dose.*

FDA Label Image

Export 10

A cross-sectional diagram illustrating the layers of an estradiol transdermal patch. It labels three components: (1) Backing, (2) Adhesive containing estradiol, and (3) Oversized Protective Liner, showing the patch’s structure for drug delivery.*

FDA Label Image

Export 11

Chemical structure of estradiol with a hydration notation indicating half a molecule of water (hemihydrate). The diagram shows the steroid backbone with hydroxyl groups.*

FDA Label Image

Estradiol Transdermal System (twice-weekly) 0.025 mg/day Carton Label (Image 13)

Estradiol 0.025 mg/day transdermal patch carton label from Mylan Pharmaceuticals Inc. The label indicates the product is a transdermal system delivering estradiol twice weekly. The package includes two systems and provides an application schedule reminder. The label also highlights the product is for prescription use and includes instructions on application and storage.*

FDA Label Image

Estradiol Transdermal System (twice-weekly) 0.0375 mg/day Carton Label (Image 14)

Estradiol 0.0375 mg/day transdermal system patch label by Mylan Pharmaceuticals Inc. The label shows the product name, strength, dosage form, and route. It includes application schedule instructions and product details such as adhesive components, storage conditions, and lot information area. The packaging is designed for a twice-weekly dosing regimen.*

FDA Label Image

Estradiol Transdermal System (twice-weekly) 0.05 mg/day Carton Label (Image 15)

Packaging label for Estradiol Transdermal System USP, 0.05 mg/day strength, delivered twice weekly. The label shows the brand name Estradiol, product strength, dosage form as a patch, and labeler Mylan Pharmaceuticals Inc. Instructions for application schedule and storage are visible, along with regulatory text and barcodes. The label emphasizes usage for transdermal delivery only.*

FDA Label Image

Estradiol Transdermal System (twice-weekly) 0.075 mg/day Carton Label (Image 16)

Estradiol 0.075 mg/day transdermal patch carton, USP, labeled for twice-weekly application. The packaging is from Mylan Pharmaceuticals Inc. and includes an application schedule checklist. The label shows the strength as 0.075 mg/day and states the product is for transdermal use only.*

FDA Label Image

Estradiol Transdermal System (twice-weekly) 0.1 mg/day Carton Label (Image 17)

Packaging label for Estradiol 0.1 mg/day transdermal patch by Mylan Pharmaceuticals Inc. The label specifies this is a twice-weekly patch delivery system and includes application schedule instructions alongside detailed product information and usage warnings. The label highlights that the product is for prescription use only and includes the NDC 0378-4623-26.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.